Efalizumab Terminated Phase 2 Trials for Sjögren's Syndrome Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00344448Pilot Study of Raptiva to Treat Sjogren's Syndrome